Visicu (MM) (NASDAQ:EICU)
Historical Stock Chart
From Sep 2019 to Sep 2024
VISICU Inc., (NASDAQ:EICU), a healthcare information technology and
clinical solutions company focused on critical care, confirmed today
that the pending reexamination of its patent, filed by iMDSoft, Inc.,
has concluded successfully with 26 claims being allowed. The VISICU
patent describes and claims a system and method for providing
continuous, expert network critical care services from a remote
location(s).
The United States Patent Office (USPTO) has concluded that the iMDSoft
patent does not anticipate any of the claims of the VISICU patent and in
fact does not do automated processing of patient data as does the VISICU
system. The 26 claims of the VISICU patent have each been differentiated
from the many cited references in two separate reexaminations. The USPTO
concluded that all of VISICU claims, with clarifying amendments, are
allowable over these references. The USPTO’s
action on the VISICU claims reaffirms VISICU’s
novel approach of centrally monitoring ICUs and determining when
intervention is warranted.
More than 180 hospitals utilize VISICU’s eICU®
Program featuring high fidelity telemedicine and proprietary early
warning and intervention software. VISICU is the first company to
receive such U.S. patent protection and the first to bring remote
critical care (eICU centers) to the marketplace.
“We are pleased to have the Patent Office
again approve the VISICU patent claims and set the record straight in
this matter, especially given the negative and misleading publicity put
in the marketplace.” said Frank Sample,
chairman and CEO of VISICU.
The U.S. Patent Office has made notification of this “Notice
of Intent” available to the public on its
Public Application Information Retrieval (PAIR) website (control number
90008276) which may be accessed through the general web site (www.uspto.gov).
A copy of the actual notice will be available on the USPTO website
shortly.
About VISICU
VISICU, Inc. (NASDAQ:EICU) is a healthcare information technology and
clinical solutions company focused on transforming the delivery of
critical care through its eICU®
Program. Through remote monitoring technology and clinical intelligence,
experienced critical care resources are leveraged to provide coverage
and early intervention for safer, more effective patient care. Currently
more than 180 hospitals, serving over 250,000 patients annually, have
partnered with VISICU to implement eICU programs. More information is
available at www.VISICU.com. VISICU®
and eICU® are
registered trademarks of VISICU, Inc. All rights reserved. All other
brand names, product names, company names, trademarks and service marks
are the property of their respective owners. visicu-g
Safe Harbor Statement
This release contains forward-looking statements that are made pursuant
to the provisions of Section 21E of the Securities and Exchange Act of
1934, as amended. These forward-looking statements involve a number of
risks and uncertainties. Investors are cautioned that statements in this
release that are not strictly historical statements constitute
forward-looking statements. It is important to note that the company’s
performance, and actual results, financial condition or business could
differ materially from those expressed in the forward-looking
statements. The words “may”,
“could”, “would”,
“should”, “outlook”,
“positions us”, “guidance”,
“expects”, “estimates”,
“intends”, “plans”,
“projects”, “anticipates”,
“believes”, “predicts”,
“potential” or the
negative of these words, variations thereof or similar expressions are
intended to identify such forward-looking statements. You should not
place undue reliance on forward-looking statements since they involve
known and unknown risks, uncertainties and other factors which are, in
some cases, beyond our control and which could materially affect actual
results, levels of activity, performance or achievements. Factors that
could cause results to differ materially from current expectations
include, but are not limited to: market acceptance of our principal
product offering and any new product releases; the price, performance
and reliability of our products and services; our ability to attract and
retain new customers and renewal rates of our existing customers;
unanticipated delays or problems in releasing new products and services;
financial and budget constraints of hospitals, changes in our pricing
practices or our competitors’ pricing
practices and changes in the healthcare industry; the introduction or
availability of competing products or services and other competitive
factors; and changes in the government regulation of our products and
services.